Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Prior Information Notice

Systemic Anti-Cancer Therapy Electronic Prescribing System - Market Engagement

  • First published: 04 October 2023
  • Last modified: 04 October 2023

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-h6vhtk-04074d
Published by:
University Hospitals Birmingham NHS Foundation Trust
Authority ID:
AA20752
Publication date:
04 October 2023
Deadline date:
-
Notice type:
Prior Information Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

University Hospitals Birmingham NHS Foundation Trust (the “Authority”) is conducting market engagement in relation to its requirement for a Electronic Prescribing solution for System Anti-Cancer Therapy (SACT).<br/><br/>University Hospitals Birmingham NHS Foundation Trust (“UHB”) is a large specialist teaching hospital that runs the Queen Elizabeth Hospital Birmingham (QEHB), Birmingham Chest Clinic, Heartlands Hospital (BHH), Good Hope Hospital (GHH), Solihull Hospital (SH) and various community services across the region. <br/><br/>The Trust is looking to source a solution which replaces the current ways of working for prescribing systemic anti-cancer therapy (SACT) for patients attending its four hospital sites. The aim is to procure a designated SACT electronic prescribing system that will provide a robust, up to date and safe prescribing platform for patients requiring SACT and in doing so reduce prescribing errors, eradicate paper prescriptions, improve operational performance, improve patient safety and outcomes, and improve ways of working for staff.<br/><br/>Suppliers who are able to offer solutions relevant to this requirement are invited to express an interest and respond to a market engagement questionnaire. Further details on how to do this are contained within the additional information section of this notice.

Full notice text

Prior information notice

This notice is for prior information only

Section I: Contracting authority

I.1) Name and addresses

University Hospitals Birmingham NHS Foundation Trust

Mindelsohn Way

Birmingham

B15 2WB

UK

Contact person: Matthew Kelsall

E-mail: matthew.kelsall@uhb.nhs.uk

NUTS: UKG3

Internet address(es)

Main address: https://www.uhb.nhs.uk/

Address of the buyer profile: https://www.uhb.nhs.uk/

I.3) Communication

Additional information can be obtained from the abovementioned address


Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:

https://health-family.force.com/s/Welcome


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Systemic Anti-Cancer Therapy Electronic Prescribing System - Market Engagement

Reference number: PROC.08.0553

II.1.2) Main CPV code

48180000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

University Hospitals Birmingham NHS Foundation Trust (the “Authority”) is conducting market engagement in relation to its requirement for a Electronic Prescribing solution for System Anti-Cancer Therapy (SACT).<br/><br/>University Hospitals Birmingham NHS Foundation Trust (“UHB”) is a large specialist teaching hospital that runs the Queen Elizabeth Hospital Birmingham (QEHB), Birmingham Chest Clinic, Heartlands Hospital (BHH), Good Hope Hospital (GHH), Solihull Hospital (SH) and various community services across the region.

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.2) Additional CPV code(s)

48000000

II.2.3) Place of performance

NUTS code:

UKG3

II.2.4) Description of the procurement

University Hospitals Birmingham NHS Foundation Trust (the “Authority”) is conducting market engagement in relation to its requirement for a Electronic Prescribing solution for System Anti-Cancer Therapy (SACT).<br/><br/>University Hospitals Birmingham NHS Foundation Trust (“UHB”) is a large specialist teaching hospital that runs the Queen Elizabeth Hospital Birmingham (QEHB), Birmingham Chest Clinic, Heartlands Hospital (BHH), Good Hope Hospital (GHH), Solihull Hospital (SH) and various community services across the region. <br/><br/>The Trust is looking to source a solution which replaces the current ways of working for prescribing systemic anti-cancer therapy (SACT) for patients attending its four hospital sites. The aim is to procure a designated SACT electronic prescribing system that will provide a robust, up to date and safe prescribing platform for patients requiring SACT and in doing so reduce prescribing errors, eradicate paper prescriptions, improve operational performance, improve patient safety and outcomes, and improve ways of working for staff.<br/><br/>Suppliers who are able to offer solutions relevant to this requirement are invited to express an interest and respond to a market engagement questionnaire. Further details on how to do this are contained within the additional information section of this notice.

II.3) Estimated date of publication of contract notice:

01/01/2024

Section IV: Procedure

IV.1) Description

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

Section VI: Complementary information

VI.3) Additional information

Suppliers wishing to participate in this market engagement exercise and express an interest in this requirement should respond to the questionnaire via the online form on the Health Family Single eCommercial System Portal (Atamis) by 13:00 on Monday 30th October 2023.<br/><br/>https://atamis-1928.my.salesforce-sites.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a078d000004zElaAAE&searchStr=&sortStr=Recently+Published&page=1&filters=&County=

VI.5) Date of dispatch of this notice

02/10/2023

Coding

Commodity categories

ID Title Parent category
48180000 Medical software package Industry specific software package
48000000 Software package and information systems Computer and Related Services

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
matthew.kelsall@uhb.nhs.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.